Oxadiazole transient receptor potential channel inhibitors
The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain. 
Genentech, Inc.
C A C A C C C
C07D A61P C07D A61P C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional
Jack Lea Robin Stuart Martin Matthew Elisia Huifen Luce Brian Aijun Chantal Francis Daniel
Terrett Constantineau-Forget Larouche-Gauthier Ward Dery Volgraf Villemure Chen Lepissier Safina Lu Grand-Maitre Beaumier Shore